Product Name:Methyl (2S)-2-(4-bromo-2-formylphenoxy)propanoate

IUPAC Name:methyl (2S)-2-(4-bromo-2-formylphenoxy)propanoate

CAS:2568669-16-7
Molecular Formula:C11H11BrO4
Purity:95%
Catalog Number:CM1078115
Molecular Weight:287.11

Packing Unit Available Stock Price($) Quantity

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:2568669-16-7
Molecular Formula:C11H11BrO4
Melting Point:-
Smiles Code:O([C@H](C(OC)=O)C)C1=C(C=O)C=C(Br)C=C1
Density:
Catalog Number:CM1078115
Molecular Weight:287.11
Boiling Point:
MDL No:
Storage:

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

NMD670
NMD Pharma A/S announces that it has dosed the first generalized myasthenia gravis patient in a Phase 2b clinical trial of NMD670, after receiving FDA IND clearance in March 2024 to conduct the study.
NMD670 is a first-in-class small molecule inhibitor of the skeletal muscle specific chloride ion channel (CIC-1). NMD Pharma has demonstrated that CIC-1 inhibition enhances weakened neuromuscular transmission and restores skeletal muscle function, and this novel treatment approach has demonstrated compelling preclinical and clinical data in animal models of myasthenia gravis, spinal muscular atrophy and a range of other neuromuscular disorders. NMD670 has also been granted orphan-drug designation by the U.S. FDA for treatment of gMG.

Related Products